Insider · CIK 0001547100
Ratcliffe Liam
Reports to the SEC for 20 companies · BOULDER, CO
Transactions
50
Companies
20
Filings
16
CIK
0001547100
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-07 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-06-18 | IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-09 | UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-04 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-03-31 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-11 | IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-10 | UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-10-10 | UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-26 | CLYMClimb Bio, Inc. · Stock Option (Right To Buy)A Award | — |
| 2024-06-12 | IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-09 | IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-05-18 | CLYMClimb Bio, Inc. · Stock Option (Right To Buy)A Award | — |
| 2022-12-29 | IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-16 | ARVNARVINAS, INC. · Stock Option (right to buy)A Award | — |
| 2022-05-19 | CLYMClimb Bio, Inc. · Stock Option (Right To Buy)A Award | — |
| 2021-12-16 | ARVNARVINAS, INC.S Sale | −$3.38M |
| 2021-12-16 | ARVNARVINAS, INC.S Sale | −$2.57M |
| 2021-12-15 | ARVNARVINAS, INC.S Sale | −$2.72M |
| 2021-12-15 | ARVNARVINAS, INC.S Sale | −$4.49M |
| 2021-12-15 | ARVNARVINAS, INC.S Sale | −$374K |
| 2021-12-14 | ARVNARVINAS, INC.S Sale | −$7.89M |
| 2021-12-14 | ARVNARVINAS, INC.S Sale | −$2.37M |
| 2021-12-14 | ARVNARVINAS, INC.S Sale | −$44.9K |
| 2021-11-15 | ARVNARVINAS, INC.S Sale | −$1.51M |
| 2021-11-15 | ARVNARVINAS, INC.S Sale | −$296K |
| 2021-11-12 | ARVNARVINAS, INC.S Sale | −$1.5M |
| 2021-11-12 | ARVNARVINAS, INC.S Sale | −$814K |
| 2021-11-12 | ARVNARVINAS, INC.S Sale | −$1.07M |
| 2021-11-11 | ARVNARVINAS, INC.S Sale | −$490K |
| 2021-11-11 | ARVNARVINAS, INC.S Sale | −$1.56M |
| 2021-11-11 | ARVNARVINAS, INC.S Sale | −$3.11M |
| 2021-11-10 | ARVNARVINAS, INC.S Sale | −$167K |
| 2021-11-10 | ARVNARVINAS, INC.S Sale | −$134K |
| 2021-11-10 | ARVNARVINAS, INC.S Sale | −$516K |
| 2021-11-10 | ARVNARVINAS, INC.S Sale | −$345K |
| 2021-11-10 | ARVNARVINAS, INC.S Sale | −$17.2K |
| 2021-11-09 | ARVNARVINAS, INC.S Sale | −$476K |
| 2021-11-09 | ARVNARVINAS, INC.S Sale | −$2.51M |
| 2021-11-09 | ARVNARVINAS, INC.S Sale | −$53K |
| 2021-11-08 | ARVNARVINAS, INC.S Sale | −$5.18M |
| 2021-11-08 | ARVNARVINAS, INC.S Sale | −$1.1M |
| 2021-11-08 | ARVNARVINAS, INC.S Sale | −$1.04M |
| 2021-11-08 | ARVNARVINAS, INC.S Sale | −$341K |
| 2021-11-05 | ARVNARVINAS, INC.M Exercise/Conversion | +$142K |
| 2021-11-05 | ARVNARVINAS, INC.M Exercise/Conversion | +$403K |
| 2021-11-05 | ARVNARVINAS, INC.S Sale | −$588K |
| 2021-11-05 | ARVNARVINAS, INC.S Sale | −$646K |
| 2021-11-05 | ARVNARVINAS, INC.S Sale | −$448K |
| 2021-11-05 | ARVNARVINAS, INC.S Sale | −$478K |
| 2021-11-05 | ARVNARVINAS, INC.S Sale | −$71.8K |
Recent filings
- 4Ratcliffe Liam0001547100-26-000005SEC(opens sec.gov)
- 4Ratcliffe Liam0001193125-26-279734SEC(opens sec.gov)
- 4Ratcliffe Liam0001193125-26-268165SEC(opens sec.gov)
- 4Ratcliffe Liam0001547100-26-000004SEC(opens sec.gov)
- 4Ratcliffe Liam0001547100-26-000003SEC(opens sec.gov)
- 4Ratcliffe Liam0000950170-25-086393SEC(opens sec.gov)
- 4Ratcliffe Liam0000950170-25-085370SEC(opens sec.gov)
- 4Ratcliffe Liam0000950170-24-114681SEC(opens sec.gov)
- 4Ratcliffe Liam0001415889-24-018461SEC(opens sec.gov)
- 4Ratcliffe Liam0000950170-24-073672SEC(opens sec.gov)
- 4Ratcliffe Liam0000899243-23-015267SEC(opens sec.gov)
- 4Ratcliffe Liam0001209191-23-031535SEC(opens sec.gov)
- 4Ratcliffe Liam0000899243-23-000301SEC(opens sec.gov)
- 4Ratcliffe Liam0001209191-22-038558SEC(opens sec.gov)
- 4Ratcliffe Liam0001209191-22-033220SEC(opens sec.gov)
- 4Ratcliffe Liam0000899243-21-048686SEC(opens sec.gov)
Companies
- Aptinyx Inc.Director
- Aravive, Inc.10% Owner
- ARRAY BIOPHARMA INCDirector
- ARVINAS, INC.DirectorARVN
- CHIMERIX INC10% Owner
- Climb Bio, Inc.DirectorCLYM
- Cogent Biosciences, Inc.DirectorCOGT
- CONCERT PHARMACEUTICALS, INC.10% Owner
- Deciphera Pharmaceuticals, Inc.Director, 10% Owner
- Disc Medicine, Inc.DirectorIRON
- Durata Therapeutics, Inc.10% Owner
- iRhythm Holdings, Inc.10% OwnerIRTC
- Iterum Therapeutics plc10% OwnerITRM
- Lite Strategy, Inc.10% OwnerLITS
- OnKure Therapeutics, Inc.DirectorOKUR
- Oxford Immunotec Global PLCFormer 10% Beneficial Owner
- Passage BIO, Inc.DirectorPASG
- PDS Biotechnology CorpDirectorPDSB
- Relypsa IncFormer 10% beneficial owner
- Upstream Bio, Inc.DirectorUPB
Address
C/O ONKURE THEREAPEUTICS, INC. 6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO, 80301